Filtration Products Inc. (EFP) (OTCBB: EMFP) announces
that it will commence testing its licensed nanotechnology-enhanced
2H filter media in conjunction with the U.S. Air Force
in mid-August 2004. This proprietary enhancement encompasses
the integration of filter media with various types
of nanotechnology solutions for the detection of,
and protection from, biological, chemical, radiological
and explosive agents.
The U.S. Air Force tests, which are expected to validate
some previous testing performed by EFP, will measure
the nano-enhanced filter media's efficacy in combating
several identified biological contaminants, including:
Staphylococcus aureas, Bacillus cereus spores, Klebsiella
pneumonia, MS2, Aspergillus niger spores and Trichophyton.
Initial tests performed at Nelson Laboratories indicated
the ability to arrest and eradicate the rapid growth
of endospores. The Nelson Laboratories tests were
conducted with bacillus thuringiensis -- an endospore
that is genotypically and phenotypically similar to
bacillus anthracis, more commonly known as anthrax.
The testing will be conducted at the U.S. Army's Edgewood
Chemical Biological Center facilities in Edgewood,
Md. under the direction of the U.S. Army Research,
Development and Engineering Command (RDECOM), which
was formerly known as the U.S. Army Soldier and Biological
Chemical Command (SBCCOM). The tests are expected
to take no longer than two weeks.
For the past 17 months, EFP has been working in conjunction
with RDECOM to test its nano-enhanced 2H filter technology
in order to accelerate the commercial development
of a number of filter technology applications and
allow for rapid procurement by the U.S. Department
of Defense. Every branch of the U.S. military has
now chosen EFP's filter media for testing. Additional
protocols and specifications will be issued by various
branches of the military and are expected to quickly
follow the Air Force tests. EFP expects that each
branch of the military will test EFP's filter media
against microorganisms that relate to their respective
RDECOM has been examining how to apply the company's
filter technology to a large number of potential applications,
including, but not limited to: biohazard masks, transportation
(aircraft, tanks, armored personnel carriers) and
buildings (military, industrial, office and residential).
The program has conducted a number of cost and user
needs analyses, economic analyses and technical viability
studies of EFP's proprietary 2H filter technology.
Over 1,000 potential applications of EFP's filter
technology have been identified by RDECOM.
MISSION -- Get the right integrated technologies into
the hands of warfighters quicker.
VISION -- To be recognized as the preeminent world
leader in research, development and engineering of
systems, whose hallmark is transitioning the right
technology in the shortest time to our soldiers.
INTENT -- The Commanding General of the U.S. Army
Materiel Command (AMC) established the U.S. Army Research,
Development & Engineering Command (RDECOM), as
a new major subordinate command within AMC. This new
command will restructure core in-house capabilities
now so we can fully exploit the enormous potential
that resides in research activities around the world.
RDECOM will respond rapidly by integrating, maturing
and demonstrating emerging technologies to field the
right equipment, in the shortest time, for our soldiers.
ECBC is the nation's principal research and development
center for chemical and biological defense. Tracing
its roots back to 1917, ECBC leverages more than 85
years of experience with live agent to develop and
enhance defense systems.
ECBC seeks opportunities to develop partnerships with
industry, academia and state and local governments
to continue achieving major technological advances
for national defense, civilian protection and industrial
competitiveness. Complementing these efforts, the
Center offers several unique facilities that provide
full life-cycle support to chemical and biological
protection, detection and monitoring capabilities.
About Emergency Filtration Products Inc.:
EFP is an air filtration products manufacturer whose
patented 2H Technology(TM) filter system has produced
filtration efficiencies of "greater than 99.99%"
at a particulate size of 0.027 microns. Its initial
products were developed for the medical market: the
Vapor Isolation Valve(TM) and RespAide(TM) CPR Isolation
Mask used for resuscitation of respiratory/cardiac
arrest cases; and the 2H Breathing Circuit Filter
for ventilators, respirators and anesthesia circuitry.
Each has received FDA approval. The company also markets
an Automated External Defibrillator Prep Kit featuring
RespAide and the NanoMask(R), a nanotechnology enhanced
environmental mask. In addition to filtration products,
the company supplies Superstat(R), a modified hemostatic
collagen, to the U.S. military for surgery and extreme
Emergency Filtration Products Inc.
WPH Consultants Ltd. (Investor Relations)
Philippe Niemetz, 800-477-7570 or 212-344-6464